
Keywords: AG; Arabinogalactan; API; active pharmaceutical ingredient; DSC; differential scanning calorimetry; GA; glycyrrhizic acid; HMG-CoA; 3-hydroxy-3-methyl-glutaryl-coenzyme A; Na2GA; disodium glycyrrhizate; PAMPA; parallel artificial membrane permeability ass